Biogen

Yesterday, the European Commission approved our treatment for amyotrophic lateral sclerosis (ALS) in adults who have a specific gene mutation.    This is the first therapy approved to target a genetic cause of ALS in the EU and we share this significant milestone with the ALS community. Read our news release: https://ow.ly/PxfG50S2Uhl #Biogen | #ALS | #RareDisease 

We’re pleased to share that the European Commission has approved our treatment for amyotrophic lateral sclerosis (ALS) in adults who have a specific gene mutation.      This milestone marks Biogen’s third rare disease therapy to be authorized for use in the EU, reflecting our long-standing commitment to addressing unmet needs for the rare disease community. Read our news release: https://ow.ly/PxfG50S2Uhl   #Biogen | #ALS | #RareDisease 

On World MS Day, we recognize those impacted by multiple sclerosis (MS). Hear from Citlali, who lives with MS, as she shares her inspiring story and how she is determined to continue living a happy life despite her diagnosis.    Learn more about World MS Day: https://ow.ly/SHeY50S1f76   #WorldMSDay | #MultipleSclerosis 

Did you know that approximately 15% of amyotrophic lateral sclerosis (ALS) cases are linked to identifiable genetic mutations? In recent years, the ALS community has expanded its understanding of the connection between genetics and ALS as we search for new approaches to advance care for people living with this devastating disease. Learn more about genetic ALS: https://ow.ly/UoqO50RYXzh #ALS | #ALSAwarenessMonth | #RareDisease

Biogen is honored to be part of this transformative initiative, AMPALS, alongside other industry leaders. Proud of our own Stephanie Melillo Fradette who is acting as co-chair in this effort to drive research, expedite treatment development and bring hope to those affected by ALS. #ALS | #RareDisease | #AMPALS

Tracey experienced pain and mobility issues for years that she chalked up to her age or arthritis. While her diagnosis with a rare genetic form of amyotrophic lateral sclerosis (ALS) in 2023 was unexpected, Tracey is moving forward with the support of her family. In honor of ALS Awareness Month, we’re sharing Tracey’s story. Learn more about ALS: https://ow.ly/ScPO50RSPPA #ALS | #ALSAwarenessMonth | #RareDisease

As we recognize Friedreich ataxia (FA) Awareness Month in May, we are inspired by individuals like Elizabeth, who share their experience living with FA to spread awareness of this rare neuromuscular disorder. Learn more about Elizabeth's inspiring story: Living with Friedreich Ataxia: Elizabeth's Story_| Biogen #FriedreichAtaxia | #FAAwarenessMonth #RareDisease

May is Maternal Mental Health Month, a time when we are reminded of the strength, courage and resilience of the millions of women who have lived with postpartum depression (PPD). This month, and all year around, it’s important to raise awareness of maternal mental health so we can work together to reduce stigma and create a safe space for women suffering from PPD. Read more: https://ow.ly/5XVq50RRnB8    #MaternalMentalHealthMonth | #MentalHealthMonth | #PostpartumDepression 

Biogen bolsters a late-stage pipeline and expands immunology portfolio with an agreement to acquire HI-Bio. Learn more about this news: https://ow.ly/aHCT50RQJUI

Today, on International Clinical Trials Day, we recognize the criticality and value of clinical trials in driving medical advancement to benefit society while protecting patient safety. By increasing participation of underrepresented populations in clinical trials – as we have done in Alzheimer’s disease, Parkinson’s disease and lupus – we believe we can better serve those living with the diseases we treat. In 2023, in collaboration with trusted partners, we held more than 35 community and faith-based events in the U.S. in an effort to advance equitable access to quality care and medicines. We will continue to work to build awareness and trust to ensure our clinical trials reflect the epidemiology of the disease. Learn how Biogen is connecting diverse communities to clinical research: https://ow.ly/fATP50RNW9T #ClinicalTrials | #InternationalClinicalTrialsDay | #HealthEquity